Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 26% ± 7% | |
| astrocyte | 4 studies | 22% ± 5% | |
| ciliated cell | 3 studies | 25% ± 5% | |
| GABAergic neuron | 3 studies | 28% ± 9% | |
| glutamatergic neuron | 3 studies | 33% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 7% | |
| basal cell | 3 studies | 20% ± 6% | |
| oligodendrocyte | 3 studies | 25% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2608.84 | 245 / 245 | 100% | 10.59 | 502 / 502 |
| thymus | 100% | 2550.38 | 653 / 653 | 100% | 11.28 | 605 / 605 |
| uterus | 100% | 1670.86 | 170 / 170 | 100% | 7.43 | 458 / 459 |
| brain | 100% | 1275.74 | 2635 / 2642 | 100% | 11.41 | 705 / 705 |
| breast | 100% | 1271.47 | 459 / 459 | 100% | 8.91 | 1113 / 1118 |
| adrenal gland | 100% | 2140.50 | 258 / 258 | 99% | 8.89 | 228 / 230 |
| bladder | 100% | 1409.90 | 21 / 21 | 99% | 7.59 | 499 / 504 |
| lung | 99% | 1073.90 | 575 / 578 | 99% | 6.80 | 1142 / 1155 |
| kidney | 100% | 1483.60 | 89 / 89 | 98% | 6.78 | 886 / 901 |
| pancreas | 99% | 607.63 | 324 / 328 | 98% | 7.60 | 175 / 178 |
| stomach | 100% | 1052.64 | 359 / 359 | 97% | 4.79 | 277 / 286 |
| esophagus | 100% | 1140.02 | 1443 / 1445 | 97% | 5.24 | 177 / 183 |
| intestine | 100% | 1388.63 | 966 / 966 | 95% | 5.01 | 500 / 527 |
| skin | 100% | 1037.16 | 1805 / 1809 | 93% | 6.63 | 438 / 472 |
| ovary | 100% | 2426.37 | 180 / 180 | 90% | 4.49 | 385 / 430 |
| liver | 98% | 626.49 | 221 / 226 | 80% | 3.88 | 325 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.01 | 29 / 29 |
| spleen | 100% | 2202.25 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.55 | 1 / 1 |
| blood vessel | 100% | 1083.49 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 946.70 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 784.93 | 844 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 5.57 | 44 / 45 |
| muscle | 89% | 458.66 | 713 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 78% | 4.24 | 62 / 80 |
| peripheral blood | 55% | 513.23 | 511 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF226 |
| Protein name | Zinc finger protein 226 |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000589160.5 ENST00000588883.5 ENST00000590524.1 Q9NYT6 K7EK05 ENST00000590467.5 ENST00000590089.5 [Q9NYT6-1] K7ERY1 ENST00000413984.6 [Q9NYT6-2] ENST00000588742.5 [Q9NYT6-2] K7ELM4 K7EQC3 ENST00000586203.5 K7EPU4 ENST00000588795.5 K7EKQ6 K7ELA3 ENST00000337433.10 [Q9NYT6-1] ENST00000454662.6 [Q9NYT6-1] ENST00000585678.5 ENST00000585560.5 ENST00000588127.5 ENST00000590578.5 ENST00000586914.5 K7ESM6 ENST00000300823.10 [Q9NYT6-2] K7EL77 ENST00000586286.5 K7EJ66 |